Regeneron Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
21.52 3.7% 602.47 18:45:53
Open Price Low Price High Price Close Price Prev Close
588.6162 570.85 603.14 602.47 580.95
more quote information »

Recent News

Date Time Source Heading
8/05/202107:57DJNRegeneron, Sanofi: Libtayo Phase 3 Study Meets Primary..
8/05/202106:59EDGARCurrent Report Filing (8-k)
8/05/202106:54SEEKRegeneron shares rise on Q2 earnings beat, FY forecast
8/05/202106:33SEEKRegeneron Pharmaceuticals EPS beats by $8.09, beats on..
8/05/202106:30PRNUSRegeneron Reports Second Quarter 2021 Financial and..
8/05/202106:23SEEKRegeneron/Sanofi stops late-stage Libtayo study early after..
8/05/202106:00PRNUSPhase 3 Trial of Libtayo® (cemiplimab-rwlc) Combined with..
8/04/202117:05PRNUSNew England Journal of Medicine Publishes Positive Phase 3..
8/04/202116:04EDGARStatement of Changes in Beneficial Ownership (4)
8/03/202107:00PRNUSRegeneron Announces the 2021 Winners of the Regeneron Prize..
8/02/202106:37TRMNRegeneron’s Antibody Gets Updated FDA Nod
7/30/202115:35SEEKRegeneron wins expanded authorization from FDA for COVID-19..
7/30/202114:44DJNRegeneron Gets Expanded EUA for Covid-19 Antibody Cocktail..
7/30/202114:16DJNRegeneron Gets Expanded EUA for Covid-19 Antibody Cocktail
7/30/202113:45PRNUSFDA Expands Authorized Use of REGEN-COV™ (casirivimab and..
7/29/202107:15DJNRegeneron, Sanofi: Dupixent Hits Endpoints in Chronic..
7/29/202100:59PRNUSDupixent® (dupilumab) Significantly Improved Itch and Hives..
7/27/202107:00PRNUSRegeneron and AstraZeneca to Research, Develop and..
7/20/202101:00PRNUSJapan Becomes First Country to Approve Regeneron Antibody..
7/19/202121:58DJNChugai Pharmaceutical Obtains Approval for Covid Antibody..
7/16/202113:13SEEKRegeneron spending $1.8B to expand footprint in New York
7/07/202116:15PRNUSRegeneron to Report Second Quarter 2021 Financial and..
7/07/202116:02EDGARStatement of Changes in Beneficial Ownership (4)
7/07/202108:26DJNSilverback Therapeutics in Supply Agreement for Libtayo With..
7/02/202116:02EDGARStatement of Changes in Beneficial Ownership (4)
7/01/202115:48SEEKRegeneron scientists discover genetic mutations associated..
7/01/202114:05PRNUSRegeneron Genetics Center Discovers GPR75 Gene Mutations..
6/30/202108:55SEEKAltimmune price targets lowered, Tilray’s next move..
6/28/202116:02EDGARStatement of Changes in Beneficial Ownership (4)
6/28/202112:42SEEKIntellia CRISPR gene editing data puts heat on Alnylam;..
6/28/202111:00TRMNRegeneron’s Dupixent Gets Label Extension in Europe to..
6/28/202108:55SEEKHot Stocks: NTLA leads gene-editing stocks higher; ABUS..
6/28/202107:17DJNIntellia Shares Climb on Positive Gene-Editing Data
6/28/202103:17SEEKEMA to update Regeneron/Sanofi's Dupixent SmPC for adults..
6/28/202100:59PRNUSDupixent® (dupilumab) SmPC Updated with Long-term Data..
6/26/202112:05SEEKIn a first, Intellia, Regeneron demonstrate CRISPR therapy..
6/26/202111:16PRNUSIntellia and Regeneron Announce Landmark Clinical Data..
6/26/202111:15GLOBEIntellia and Regeneron Announce Landmark Clinical Data..
6/25/202101:45SEEKRegeneron/Sanofi's Libtayo OK'd in Europe for lung cancer..
6/25/202101:38SEEKRegeneron/Sanofi's Libtayo OK'd in Europe for skin cancer
6/25/202101:15PRNUSLibtayo® (cemiplimab) Approved by the European Commission as..
6/25/202101:00PRNUSLibtayo® (cemiplimab) Approved by the European Commission..
6/23/202116:03EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202116:15PRNUSRegeneron to Participate in Guggenheim Biopharma Strategy..
6/21/202110:45TRMNBioNTech Begins Patient Dosing in Phase 2 Cancer Vaccine..
6/16/202116:37EDGARCurrent Report Filing (8-k)
6/16/202116:04EDGARStatement of Changes in Beneficial Ownership (4)
6/16/202116:03EDGARStatement of Changes in Beneficial Ownership (4)
6/16/202101:33SEEKRegeneron's REGEN-COV reduces death by 20% in hospitalized..
6/16/202101:00PRNUSREGEN-COV™ (casirivimab and imdevimab) Phase 3 RECOVERY..
See more news about this stock »

Your Recent History
Regeneron ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.